Cutter Capital Management, LP Sarepta Therapeutics, Inc. Transaction History
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
A detailed history of Cutter Capital Management, LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 89,379 shares of SRPT stock, worth $10.1 Million. This represents 4.26% of its overall portfolio holdings.
Number of Shares
89,379
Previous 94,379
5.3%
Holding current value
$10.1 Million
Previous $12.2 Billion
15.58%
% of portfolio
4.26%
Previous 4.67%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
547Shares Held
87MCall Options Held
3.69MPut Options Held
1.79M-
Black Rock Inc. New York, NY10.3MShares$1.16 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.01 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$704 Million0.16% of portfolio
-
State Street Corp Boston, MA4.27MShares$480 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$429 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.85B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...